Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cellegy Pharmaceuticals (CLGY) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (202)	10/28/1999 12:46:00 AM
From: Howard Hoffman	Read Replies (2) \| Respond to of 322

You are right. No one is paying attention because: The market cap is too small (<$100M) for many. The lack of an approved drug makes many risk-averse people stay away. The lack of volume and upward momentum keeps the momentum players away. This is exactly the time for you and me to buy up shares. I increased my position by 15% this week. We just have to be patient. When CLGY becomes a billion dollar cap company, then everyone will be falling all over themselves with upgrades. It is nice to be in early. By the way, I pass by South San Francisco where CLGY is located several times each month. In fact, I will be driving by tomorrow and Friday. Has anyone visited their offices? Would there be any value in my trying to set up a visit?